🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Peter Wiklund

Icahn School of Medicine at Mount Sinai

ORCID: 0000-0001-6497-4697
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO”.

Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO

European Urology Open Science(2020)10.1016/j.euros.2020.06.005
N/A
0DataRank · unranked
10 citations

Olof Akre, David Bock, Sigrid Carlsson, Stefan Carlsson, Jonas Hugosson +8 more

Myeloid cell-associated resistance to PD-1/PD-L1 blockade in urothelial cancer revealed through bulk and single-cell RNA sequencing

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.16.300111
N/A
0DataRank · unranked
20 citations

John P. Sfakianos, Kristin G. Beaumont, Güray Aktürk, Amir Horowitz, Robert Sebra +16 more

Myeloid Cell–associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4574
N/A
0DataRank · unranked
89 citations

John P. Sfakianos, Kristin G. Beaumont, Güray Aktürk, Amir Horowitz, Robert Sebra +16 more

Role of α- and β-adrenergic signaling in phenotypic targeting: significance in benign and malignant urologic disease

Cell Communication and Signaling(2021)10.1186/s12964-021-00755-6
N/A
0DataRank · unranked
37 citations

Navneet Dogra, Zach Dovey, Teja Ganta, Hee‐Seong Jang, Johnathan A. Khusid +20 more

The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic

Frontiers in Oncology(2021)10.3389/fonc.2021.734963
N/A
0DataRank · unranked
7 citations

Dara Lundon, Nihal Mohamed, Andrew Katims, Vaibhav G. Patel, Benjamin Eilender +11 more

NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer

Cancer Cell(2022)10.1016/j.ccell.2022.08.005
N/A
0DataRank · unranked
131 citations

John P. Sfakianos, Daniel Ranti, Jorge Daza, Christine Bieber, Andrew Charap +46 more

NKG2A and HLA-E define a novel alternative immune checkpoint axis in bladder cancer

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.04.482960
N/A
0DataRank · unranked
1 citations

John P. Sfakianos, Jorge Daza, Andrew Charap, Christian Hammer, Romain Banchereau +42 more

Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using Randomized Controlled Trials

European Urology(2023)10.1016/j.eururo.2023.04.004
N/A
0DataRank · unranked
106 citations

Joanna Wong, Wei Phin Tan, Thiara Rupasinghe, Wei Shen Tan, Stephen B. Williams +10 more

Urine scRNAseq reveals new insights into the bladder tumor immune microenvironment

The Journal of Experimental Medicine(2024)10.1084/jem.20240045
N/A
0DataRank · unranked
25 citations

D. Youssef, Sanjana Shroff, Disha Chowhan, Kristin G. Beaumont, Robert Sebra +9 more